PubNub Evolves Its Platform with AI-Native Development, Real-Time Moderation, and Decision Intelligence
AI meets interactivity with built-in moderation, generative coding, and instant optimization for next-gen digital experiences.
PubNub, the leader in real-time interactive apps, unveiled the next evolution of its platform. It introduces AI-native development, real-time decision intelligence, and in-network content moderation to help developers build and scale faster while simplifying access to PubNub's full power.
The updates enable developers to build rich, real-time experiences like multiplayer games, collaborative tools, and healthcare apps with greater speed and control.
“The world expects real-time, intelligent experiences,” said Todd Greene, CEO, PubNub. “Our evolved platform brings AI, analytics, and moderation into the developer workflow, enabling safer, smarter apps with lower latency and greater impact.”
New Capabilities That Redefine Real-Time:
Generative AI Coding with MCP Server
PubNub’s new Model Context Protocol (MCP) Server connects large language models (LLMs) like those in AI-powered IDEs (e.g., Cursor, Windsurf) directly to live SDK knowledge. Developers can generate real-time features like chat, presence, or sync with a single prompt, without leaving their editor or searching documentation.
AI-Powered Auto-Moderation
BizOps Workspace offers built-in content filtering that runs in-cluster before messages are delivered to users. This serverless module scans messages for profanity, abuse, and spam in sub-500ms, with no external setup. Developers can apply preset rules or connect third-party tools, all from a no-code interface with no backend work.
Decision Intelligence with PubNub Illuminate & Insights
PubNub’s decisioning tools let teams monitor and optimize live applications with no-code dashboards, real-time anomaly detection, and automation rules. Product and engineering teams can optimize user flows, test changes, and respond to real-time behavior without redeploying.
“We’re closing the gap between ideation and execution,” said Stephen Blum, CTO, PubNub. “With generative coding, real-time decision engines, and in-network moderation, developers can build better apps faster and scale confidently.”
Why It Matters
- Accelerated development: AI tools reduce time-to-feature.
- Built-in safety: In-network moderation blocks harmful content.
- Live optimization: Adapt in real time.
- Enterprise-ready: Sub-100ms latency, 99.999% uptime, and full compliance (HIPAA, SOC 2, GDPR, ISO 27001).
About PubNub
PubNub powers real-time interactive experiences that drive engagement, retention, and monetization. Our platform enables over 2,000 companies to build, manage, and optimize apps that captivate users. Founded in 2012, PubNub is backed by investors like The Raine Group, Sapphire, Scale, Relay, Cisco, Bosch, Ericsson, and HPE. Start building at www.pubnub.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250611327297/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Technology Reply earns Oracle Service Expertise in Artificial Intelligence for the Western Europe region13.6.2025 10:00:00 CEST | Press release
Technology Reply, a company of the Reply Group specialising in the design of solutions based on Oracle technologies, has been presented with the Oracle Service Expertise in Artificial Intelligence for the Western Europe region, further consolidating its position as a key partner for AI projects on Oracle Cloud Infrastructure (OCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613439196/en/ Thanks to this certification, Technology Reply strengthens its role as a technology partner for companies seeking to enhance their enterprise applications, improve user interaction, and accelerate decision-making processes through artificial intelligence and Oracle technologies. The Service Expertise certification is in recognition of Technology Reply’s technical and design capabilities in building solutions based on OCI’s AI services, including the use of pre-trained models, chatbot development, custom model creation, and the adoptio
Lone Star Announces Sale of novobanco to BPCE13.6.2025 09:00:00 CEST | Press release
Transaction is testament to novobanco’s transformation into one of Europe’s most profitable banks, and trusted partner for Portuguese households and SMEs BPCE brings the strength of a major European banking group to novobanco The acquisition, expected to close in H1 2026, represents a significant vote of confidence in the Portuguese banking sector and the country’s economic future Nani Holdings S.à. r.l., an affiliate of Lone Star Funds (“Lone Star”), today announced that it has signed a Memorandum of Understanding for the sale of Novo Banco, S.A. (“novobanco” or “the bank”), Portugal’s fourth-largest bank, to BPCE, a leading European banking institution, for a cash consideration payable at closing which values 100% of the share capital at an estimated €6.4 billion as of end 2025. This transaction marks the culmination of a multi-year transformation of novobanco since Lone Star acquired 75% of the bank in 2017. Under Lone Star’s stewardship, in cooperation with other shareholders, novo
xFusion Unveils Breakthrough High-Performance Computing Innovations at ISC 202513.6.2025 05:33:00 CEST | Press release
xFusion International Pte. Ltd (xFusion) showcased its latest advancements in high-performance computing (HPC) and sustainable intelligent computing solutions at the International Supercomputing Conference (ISC) 2025, held from June 10 to 13 in Hamburg, Germany. As a global leader in HPC and computing infrastructure, xFusion highlighted its commitment to empowering industries and institutions with cutting-edge technologies that accelerate innovation and digital transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612879566/en/ Arthur Wang Revolutionizing Computing with Innovative Solutions At the Vendor Roadmap Session on June 12, Arthur Wang, Director of xFusion Computing Solution, delivered a compelling keynote titled "Innovative Computing with xFusion." Arthur emphasized the increasing demand for computing power in the age of AI and intelligent agents, as well as xFusion’s role in addressing these challenges.
Kao Releases the Kao Integrated Report 202513.6.2025 04:00:00 CEST | Press release
Kao Corporation (TOKYO:4452) has published the Kao Integrated Report 2025 on its website, offering shareholders, investors, and all stakeholders with a comprehensive overview of the company’s initiatives and strategic direction. Kao Integrated Report 2025 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250609991718/en/ The cover visual represents our “moonshot.” It embodies our commitment to achieving the ambitious goal of a sustainable society for future generations. To achieve its Mid-term Plan “K27,” Kao aims to become a unique presence indispensable to someone in the world and is advancing its Global Sharp Top strategy. In FY2024, Kao exceeded its targets by strengthening Return on Invested Capital (ROIC) management and strategically investing to build stronger, more robust businesses. This report offers an in-depth look at Kao’s progress under K27, highlighting how Kao’s dedicated employees—through the Global Sharp Top s
Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 00:45:00 CEST | Press release
POD1UM-303/InterAACT 2 is the first and largest global Phase 3 trial evaluating a PD-1 inhibitor in combination with chemotherapy for the treatment of patients with advanced SCAC not previously treated with systemic chemotherapy The trial met its primary endpoint; treatment with retifanlimab in combination with platinum-based chemotherapy (carboplatin-paclitaxel) resulted in clinically meaningful improvements in progression-free survival and overall survival In May 2025, the U.S. Food and Drug Administration (FDA) approved Zynyz® (retifanlimab-dlwr) in combination with carboplatin and paclitaxel and as a single agent for the treatment of advanced SCAC; submissions to other global regulatory agencies are also under review Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-base
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom